MR Imaging and MR Spectroscopy in Prostate Cancer Management

Radiologic Clinics of North America

Volumn 44, Issue 5, 2006, Pages 723-734

  Katz, Sharyn ^a   Rosen, Mark ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDE; PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COMPUTER AIDED DESIGN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SIGNAL NOISE RATIO; TREATMENT PLANNING; ULTRASOUND;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; EQUIPMENT DESIGN; HUMANS; IMAGE ENHANCEMENT; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 33749349146     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2006.07.008     Document Type: Review

References (60)

1. American Cancer Society. Cancer facts and figures 2005 (2005), American Cancer Society, Atlanta (GA)
2. Potosky A.L., Miller B.A., Albertsen P.C., et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA 273 (1995) 548-552
3. Roberts R.O., Bergstralh E.J., Katusic S.K., et al. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol 161 (1999) 529-533
4. Moul J.W., Wu H., Sun L., et al. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery 132 (2002) 213-219
5. Etzioni R., Penson D.F., Legler J.M., et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 94 (2002) 981-990
6. Schnall M.D., Lenkinski R.E., Pollack H.M., et al. Prostate: MR imaging with an endorectal surface coil. Radiology 172 (1989) 570-574
7. Perrotti M., Han K.R., Epstein R.E., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 162 (1999) 1314-1317
8. Beyersdorff D., Taupitz M., Winkelmann B., et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224 (2002) 701-706
9. Saigal C.S., Pashos C.L., Henning J.M., et al. Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology 59 (2002) 400-404
10. Liney G.P., Turnbull L.W., and Knowles A.J. A simple method for the correction of endorectal surface coil inhomogeneity in prostate imaging. J Magn Reson Imaging 8 (1998) 994-997
11. White S., Hricak H., Forstner R., et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195 (1995) 385-390
12. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 (2002) 91-97
13. Blute M.L., Bergstralh E.J., Iocca A., et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 165 (2001) 119-125
14. Han M., Partin A.W., Zahurak M., et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169 (2003) 517-523
15. Schellhammer P.F. Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 31 (1988) 191-197
16. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
17. D'Amico A.V., Whittington R., Schnall M., et al. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer 75 (1995) 2368-2372
18. Langlotz C.P., Schnall M.D., Malkowicz S.B., et al. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Acad Radiol 3 Suppl 1 (1996) S24-S27
19. Langlotz C., Schnall M., and Pollack H. Staging of prostatic cancer: accuracy of MR imaging. Radiology 194 (1995) 645-646 [discussion: 647-8]
20. D'Amico A.V. The role of MR imaging in the selection of therapy for prostate cancer. Magn Reson Imaging Clin N Am 4 (1996) 471-479
21. Hricak H., Wang L., Wei D.C., et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100 (2004) 2655-2663
22. Yu K.K., and Hricak H. Imaging prostate cancer. Radiol Clin North Am 38 (2000) 59-85 [viii]
23. Kurhanewicz J., Vigneron D.B., Hricak H., et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 198 (1996) 795-805
24. Wang L., Hricak H., Kattan M.W., et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238 (2006) 597-603
25. Futterer J.J., Scheenen T.W., Huisman H.J., et al. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39 (2004) 671-680
26. Bloch B.N., Rofsky N.M., Baroni R.H., et al. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils: initial experience (1). Acad Radiol 11 (2004) 863-867
27. De Meerleer G., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 75 (2005) 325-333
28. Buyyounouski M.K., Horwitz E.M., Price R.A., et al. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys 58 (2004) 743-749
29. Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 857-865
30. DiBiase S.J., Hosseinzadeh K., Gullapalli R.P., et al. Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 429-438
31. Zaider M., Zelefsky M.J., Lee E.K., et al. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47 (2000) 1085-1096
32. Mizowaki T., Cohen G.N., Fung A.Y., et al. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54 (2002) 1558-1564
33. Huisman H.J., Futterer J.J., van Lin E.N., et al. Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers. Radiology 236 (2005) 311-317
34. Hirose M., Bharatha A., Hata N., et al. Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy. Acad Radiol 9 (2002) 906-912
35. Atalar E., and Menard C. MR-guided interventions for prostate cancer. Magn Reson Imaging Clin N Am 13 (2005) 491-504
36. Susil R.C., Camphausen K., Choyke P., et al. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med 52 (2004) 683-687
37. Menard C., Susil R.C., Choyke P., et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys 59 (2004) 1414-1423
38. D'Amico A.V., Cormack R.A., and Tempany C.M. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med 344 (2001) 776-777
39. D'Amico A.V., Cormack R., Tempany C.M., et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 507-515
40. Cormack R.A., Kooy H., Tempany C.M., et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46 (2000) 207-214
41. Kaplan I., Oldenburg N.E., Meskell P., et al. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging 20 (2002) 295-299
42. Huch Boni R.A., Boner J.A., Lutolf U.M., et al. Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 19 (1995) 232-237
43. Noworolski S.M., Henry R.G., Vigneron D.B., et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 53 (2005) 249-255
44. Buckley D.L., Roberts C., Parker G.J., et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 233 (2004) 709-715
45. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
46. Schlemmer H.P., Merkle J., Grobholz R., et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?. Eur Radiol 14 (2004) 309-317
47. Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
48. Futterer J.J., Engelbrecht M.R., Huisman H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 (2005) 541-549
49. Shimofusa R., Fujimoto H., Akamata H., et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 29 (2005) 149-153
50. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
51. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
52. van Dorsten F.A., van der Graaf M., Engelbrecht M.R., et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20 (2004) 279-287
53. Rockall A.G., Sohaib S.A., Harisinghani M.G., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821
54. Deserno W.M., Harisinghani M.G., Taupitz M., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233 (2004) 449-456
55. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
56. Sella T., Schwartz L.H., Swindle P.W., et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231 (2004) 379-385
57. Silverman J.M., and Krebs T.L. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 168 (1997) 379-385
58. Chan T.W., and Kressel H.Y. Prostate and seminal vesicles after irradiation: MR appearance. J Magn Reson Imaging 1 (1991) 503-511
59. Pucar D., Shukla-Dave A., Hricak H., et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236 (2005) 545-553
60. Coakley F.V., Teh H.S., Qayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233 (2004) 441-448